vs
Side-by-side financial comparison of Stabilis Solutions, Inc. (SLNG) and STRATA Skin Sciences, Inc. (SSKN). Click either name above to swap in a different company.
Stabilis Solutions, Inc. is the larger business by last-quarter revenue ($13.3M vs $9.3M, roughly 1.4× STRATA Skin Sciences, Inc.). STRATA Skin Sciences, Inc. runs the higher net margin — 0.6% vs -2.0%, a 2.6% gap on every dollar of revenue. On growth, STRATA Skin Sciences, Inc. posted the faster year-over-year revenue change (-3.0% vs -23.3%). STRATA Skin Sciences, Inc. produced more free cash flow last quarter ($-551.0K vs $-2.5M). Over the past eight quarters, STRATA Skin Sciences, Inc.'s revenue compounded faster (17.3% CAGR vs -18.1%).
Stabilis Solutions, Inc.SLNGEarnings & Financial Report
Stabilis Solutions, Inc. is a leading North American small-scale liquefied natural gas (LNG) producer and distributor. It supplies LNG fuel, cryogenic services, and full-cycle energy solutions to industrial, remote power, transportation, and commercial clients across the United States and Canada, advancing low-emission energy transition efforts.
Strata Skin Sciences is an American medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations.
SLNG vs SSKN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.3M | $9.3M |
| Net Profit | $-262.0K | $58.0K |
| Gross Margin | 24.7% | 61.8% |
| Operating Margin | -2.4% | 5.3% |
| Net Margin | -2.0% | 0.6% |
| Revenue YoY | -23.3% | -3.0% |
| Net Profit YoY | -112.4% | 101.3% |
| EPS (diluted) | — | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.3M | $9.3M | ||
| Q3 25 | $20.3M | $6.9M | ||
| Q2 25 | $17.3M | $7.7M | ||
| Q1 25 | $17.3M | $6.8M | ||
| Q4 24 | $17.3M | $9.6M | ||
| Q3 24 | $17.6M | $8.8M | ||
| Q2 24 | $18.6M | $8.4M | ||
| Q1 24 | $19.8M | $6.8M |
| Q4 25 | $-262.0K | $58.0K | ||
| Q3 25 | $1.1M | $-1.6M | ||
| Q2 25 | $-613.0K | $-2.6M | ||
| Q1 25 | $-1.6M | $-2.1M | ||
| Q4 24 | $2.1M | $-4.6M | ||
| Q3 24 | $997.0K | $-2.1M | ||
| Q2 24 | $27.0K | $-91.0K | ||
| Q1 24 | $1.5M | $-3.4M |
| Q4 25 | 24.7% | 61.8% | ||
| Q3 25 | 27.6% | 60.4% | ||
| Q2 25 | 26.5% | 56.2% | ||
| Q1 25 | 26.2% | 53.5% | ||
| Q4 24 | 28.5% | 61.4% | ||
| Q3 24 | 28.3% | 60.1% | ||
| Q2 24 | 27.1% | 59.0% | ||
| Q1 24 | 31.6% | 45.6% |
| Q4 25 | -2.4% | 5.3% | ||
| Q3 25 | 5.5% | -16.9% | ||
| Q2 25 | -2.4% | -30.1% | ||
| Q1 25 | -9.7% | -25.0% | ||
| Q4 24 | 12.8% | -44.7% | ||
| Q3 24 | 5.0% | -18.2% | ||
| Q2 24 | 2.4% | -5.7% | ||
| Q1 24 | 7.8% | -42.7% |
| Q4 25 | -2.0% | 0.6% | ||
| Q3 25 | 5.5% | -23.4% | ||
| Q2 25 | -3.5% | -33.6% | ||
| Q1 25 | -9.2% | -31.2% | ||
| Q4 24 | 12.2% | -47.6% | ||
| Q3 24 | 5.7% | -23.6% | ||
| Q2 24 | 0.1% | -1.1% | ||
| Q1 24 | 7.4% | -49.8% |
| Q4 25 | — | $0.14 | ||
| Q3 25 | $0.06 | $-0.36 | ||
| Q2 25 | $-0.03 | $-0.62 | ||
| Q1 25 | $-0.09 | $-0.51 | ||
| Q4 24 | $0.12 | $-2.01 | ||
| Q3 24 | $0.05 | $-0.51 | ||
| Q2 24 | $0.00 | $-0.03 | ||
| Q1 24 | $0.08 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.5M | $7.9M |
| Total DebtLower is stronger | $7.9M | $15.3M |
| Stockholders' EquityBook value | $66.7M | $2.9M |
| Total Assets | $83.1M | $30.5M |
| Debt / EquityLower = less leverage | 0.12× | 5.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.5M | $7.9M | ||
| Q3 25 | $10.3M | $7.1M | ||
| Q2 25 | $12.2M | $6.0M | ||
| Q1 25 | $9.0M | $6.5M | ||
| Q4 24 | $9.0M | $7.3M | ||
| Q3 24 | $12.4M | $7.1M | ||
| Q2 24 | $11.5M | $5.5M | ||
| Q1 24 | $8.3M | $5.2M |
| Q4 25 | $7.9M | $15.3M | ||
| Q3 25 | $8.3M | $15.3M | ||
| Q2 25 | $7.6M | $15.0M | ||
| Q1 25 | $8.3M | $15.0M | ||
| Q4 24 | $8.9M | $15.0M | ||
| Q3 24 | $9.3M | $15.0M | ||
| Q2 24 | $8.6M | $15.0M | ||
| Q1 24 | $9.1M | $15.0M |
| Q4 25 | $66.7M | $2.9M | ||
| Q3 25 | $66.7M | $1.3M | ||
| Q2 25 | $65.5M | $532.0K | ||
| Q1 25 | $65.9M | $3.0M | ||
| Q4 24 | $67.0M | $5.0M | ||
| Q3 24 | $65.4M | $9.4M | ||
| Q2 24 | $63.7M | $9.5M | ||
| Q1 24 | $63.2M | $9.4M |
| Q4 25 | $83.1M | $30.5M | ||
| Q3 25 | $87.1M | $30.7M | ||
| Q2 25 | $83.2M | $29.5M | ||
| Q1 25 | $83.1M | $33.0M | ||
| Q4 24 | $85.6M | $34.9M | ||
| Q3 24 | $89.3M | $39.4M | ||
| Q2 24 | $82.6M | $38.8M | ||
| Q1 24 | $80.6M | $39.2M |
| Q4 25 | 0.12× | 5.28× | ||
| Q3 25 | 0.12× | 11.65× | ||
| Q2 25 | 0.12× | 28.20× | ||
| Q1 25 | 0.13× | 5.04× | ||
| Q4 24 | 0.13× | 3.02× | ||
| Q3 24 | 0.14× | 1.60× | ||
| Q2 24 | 0.13× | 1.58× | ||
| Q1 24 | 0.14× | 1.59× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $669.0K | $-239.0K |
| Free Cash FlowOCF − Capex | $-2.5M | $-551.0K |
| FCF MarginFCF / Revenue | -18.6% | -5.9% |
| Capex IntensityCapex / Revenue | 23.7% | 3.4% |
| Cash ConversionOCF / Net Profit | — | -4.12× |
| TTM Free Cash FlowTrailing 4 quarters | $462.0K | $-4.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $669.0K | $-239.0K | ||
| Q3 25 | $2.4M | $-64.0K | ||
| Q2 25 | $4.5M | $-1.9M | ||
| Q1 25 | $1.0M | $-550.0K | ||
| Q4 24 | $2.2M | $703.0K | ||
| Q3 24 | $2.6M | $-302.0K | ||
| Q2 24 | $5.0M | $591.0K | ||
| Q1 24 | $3.9M | $-804.0K |
| Q4 25 | $-2.5M | $-551.0K | ||
| Q3 25 | $-1.5M | $-1.1M | ||
| Q2 25 | $3.9M | $-2.0M | ||
| Q1 25 | $538.0K | $-749.0K | ||
| Q4 24 | $-3.4M | $199.0K | ||
| Q3 24 | $1.2M | $-364.0K | ||
| Q2 24 | $3.7M | $246.0K | ||
| Q1 24 | $3.1M | $-1.5M |
| Q4 25 | -18.6% | -5.9% | ||
| Q3 25 | -7.3% | -15.6% | ||
| Q2 25 | 22.4% | -26.1% | ||
| Q1 25 | 3.1% | -11.0% | ||
| Q4 24 | -19.7% | 2.1% | ||
| Q3 24 | 7.1% | -4.1% | ||
| Q2 24 | 19.7% | 2.9% | ||
| Q1 24 | 15.5% | -22.6% |
| Q4 25 | 23.7% | 3.4% | ||
| Q3 25 | 19.1% | 14.7% | ||
| Q2 25 | 3.7% | 0.8% | ||
| Q1 25 | 2.8% | 2.9% | ||
| Q4 24 | 32.3% | 5.3% | ||
| Q3 24 | 7.4% | 0.7% | ||
| Q2 24 | 7.4% | 4.1% | ||
| Q1 24 | 4.4% | 10.7% |
| Q4 25 | — | -4.12× | ||
| Q3 25 | 2.14× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.03× | — | ||
| Q3 24 | 2.56× | — | ||
| Q2 24 | 186.59× | — | ||
| Q1 24 | 2.67× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SLNG
| Natural Gas Gathering Transportation Marketing And Processing | $11.1M | 84% |
| Other | $1.3M | 10% |
| Services | $897.0K | 7% |
SSKN
| Dermatology Recurring Procedures | $6.1M | 65% |
| Dermatology Procedures Equipment | $3.2M | 35% |
